Stay updated on Pembrolizumab in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Endometrial Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA platform revision was updated from v3.5.3 to v3.5.4, indicating an underlying update to the site. It does not modify the study information or how the page is used.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page’s footer revision/version indicator changes from **Revision: v3.5.0** to **Revision: v3.5.3**, reflecting an update to the ClinicalTrials.gov site build rather than any study content.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check91 days agoChange DetectedAdded the page revision tag 'Revision: v3.4.3' and removed the previous 'Revision: v3.4.2' tag.SummaryDifference0.1%

- Check113 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check120 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page footer; no substantive changes to study data, eligibility criteria, or results are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Endometrial Cancer Clinical Trial page.